HRMY - Harmony Biosciences Holdings, Inc.

Across the last three months, Harmony Biosciences Holdings, Inc.'s insiders have reduced their positions by a net 72,406 shares worth roughly $3.1M.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Sandip Kapadia	24.5K	$907.8K	-
Other	Kumar Budur	13.1K	$485.5K	-
CEO	Jeffrey M. Dayno	7.3K	$271.9K	-
Other	Adam H. Zaeske	4.3K	$160.2K	-
Other	Andrew Serafin	1.5K	$54.6K	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 2, 2022	Andrew Serafin	Chief Strategy Officer	Sale+OE	38,000	$60.13	$2,285,099.92	-	-29.0%	-49.6%
Dec 1, 2022	Jack Nielsen76	Director	Sell	129,652	$59.29	$7,686,960.37	-4.6%	-28.6%	-49.2%
Nov 22, 2022	Jack Nielsen76	Director	Sell	77,600	$57.27	$4,444,333.04	-2.7%	-24.4%	-50.8%
Nov 15, 2022	Andreas Wicki71	Director	Sell	51,278	$59.31	$3,041,490.80	-2.2%	-16.3%	-55.1%
Nov 15, 2022	Jack Nielsen76	Director	Sell	158,400	$57.58	$9,121,099.30	-5.2%	-16.3%	-55.1%
Nov 10, 2022	Andreas Wicki71	Director	Sell	129,408	$58.89	$7,620,541.30	-5.3%	-16.8%	-59.5%
Nov 4, 2022	Andreas Wicki71	Director	Sell	576,767	$59.09	$34,079,776.10	-19.1%	-17.0%	-56.0%
Nov 3, 2022	Jeffrey M. Dayno54	Chief Medical Officer	Sale+OE	15,000	$60.02	$900,331.50	-	-19.6%	-56.8%
Nov 1, 2022	Jeffrey M. Dayno54	Chief Medical Officer	Sale+OE	15,000	$55.10	$826,558.50	-	-19.4%	-58.6%
Oct 3, 2022	Jeffrey Dierks62	Chief Commercial Officer	Sale+OE	12,173	$44.68	$543,915.98	-	+16.7%	-28.7%